chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I started feeling very fatigued around 5 pm. By 6 pm I had developed chills, body aches and I couldn?t raise my right arm higher than chest height without a lot of pain. I was feverish overnight but felt too bad to get up and take my temperature. I was also nauseated overnight and all the next day. I was very fatigued and nauseated on Fri until finally felt better around 5 pm on Friday.
Patient called the pharmacy today to report that three days after she had gotten the SHINGRIX shot, she began to break out on her face, eyes and around her trunk.
Fever to 100.7; Headache; body aches; tiredness; sore arm; blurred vision; overall feeling unwell; This is a spontaneous report from a contactable consumer (patient). A 58-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: Unknown), via an unspecified route on 02Mar2021 at 01:30 (at the age of 58-years) as dose 1, single in the left arm for covid-19 immunisation. The patient medical history included dry sinuses and sinus irritation, COVID-19 and known allergies to Penicillin. The patient concomitant medications included Prednisone from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 03Mar2021 at 12:00, the patient experienced fever to 100.7. headache, body aches, tiredness, sore arm, blurred vision, overall feeling unwell. The patient did not receive treatment for events. The outcome of the events was recovering.  No Follow-up attempts are possible. Information about lot/batch cannot be obtained.
Patient received flu shot on left deltoid 08-20-2020. She called on 08-23-2020 to let us know that she experienced the following symptoms: upset stomach, diarrhea, nausea, and congestion. She experienced these starting about 12 hours after the shot through Saturday. She did not receive any treatment from us, and reported to us once she felt back to normal.
night sweats; slight rash on face like acne; slight headache; This spontaneous case was reported by a consumer and describes the occurrence of NIGHT SWEATS (night sweats), RASH (slight rash on face like acne) and HEADACHE (slight headache) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for an unknown indication.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced NIGHT SWEATS (night sweats), RASH (slight rash on face like acne) and HEADACHE (slight headache). On 02-Apr-2021, RASH (slight rash on face like acne) and HEADACHE (slight headache) had resolved. At the time of the report, NIGHT SWEATS (night sweats) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-116382 (Patient Link).
it was rpt from territory representative concerning pt who was vax & devel fever, irritability & generalized rash;
The Night after I took the second dose of the oral Typhoid vaccine, I became violently ill with vomiting, diarrhea & headache.  Upset stomach discomfort, fatigue & headache continued for 4 -5 days afterward.
received her first shot / 1 year ago / has not received a second shot; after / first shot / was sick in bed for 3 days; This case was reported by a consumer and described the occurrence of sickness in a 84-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included rheumatoid arthritis and white blood cell count low (low white count).   In December 2019, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than a year after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced sickness and incomplete course of vaccination. On an unknown date, the outcome of the sickness was recovered/resolved and the outcome of the incomplete course of vaccination was unknown.   It was unknown if the reporter considered the sickness to be related to Shingrix.  Additional details were provided as follows: The patient had reported the case for herself. The age at vaccination was not applicable for the second suspect vaccine. The patient received her first shot of Shingrix 1 year ago from the reporting date and has not received a second shot till the time of reporting, which led to incomplete course of vaccination. The patient's doctor advised her against a second shot of Shingrix because after first shot she was sick in bed for 3 days. The reporter did not consent to follow-up.
Patient was supposed to get a Flu shot but was confused and received the Pfizer COVID shot instead.  She had received both of  the Moderna Covid shots in Feb/March of 2021.  No adverse events happened the patient just received an Pfizer shot.
After receiving the vaccine earlier in the day, Patient had trouble sleeping that night and just "wasn't feeling well". While showering she was shaving her right axillary area and noticed swelling. She felt that her lymph nodes were what had swelled. Upon examination, moderate swelling noted in the axillary area with no redness and no warmth to the touch. Patient denied any fevers or chills. Her only complaint was not feeling well, "run down" and visible as well as palpable swelling.
*HEADACHE *SORE LEFT ARM SHOULDER/SWELLING *DIZZINESS *BRAIN FOG I received the Moderna vaccine on January 6, 2011.I had a slight headache on occasion. My arm was very sore as well. I was en route to work on January 7, 2021. I  remember that I was driving, proceeding through a green light that seemed to be hazy. I hit a car that pulled in my path that had the right of way. I don't remember the impact even-though it was a very hard collision. I was 100% sure that it was the other person's fault until several days later stating that the other other person had the right to proceed. I was very lucky that nobody was seriously injured. I suffered a fractured wrist and fingers. My doctor stated that it "MAY" have been an side effect from receiving the vaccine to cause me to see or think that the light was green. I have had brain fog off and on. Ex- I would be in a conversation and during the conversation and have to stop and think about what i was talking about.
one day after - fever of 101.2, body aches (flu-like symptoms), light headed two days after - red rash on arm at site of injection  - itchy/hot/painful
Pt recvd vax 14SEP92 on 15SEP92 t103 ax 6PM; APAP given; pt went to bed mom checked noted snot in nose & weak respirations; CPR was started; squad called pulse 180, resp 80, pupils sluggish, rigid extremities dx apnea;
Swelling & erythema at (L) upper arm approximately 9 x 5 cm.
Injection site pain, swelling, heat, redness, hardness, tenderness, severe joint pain, fever, chills, chattering teeth,  sinus pressue pain, nausea, vomiting, weakness, profuse sweating, dizziness, loss of consciousness, seizure
Red, swollen, hot to the touch.  Reaction began 24 hrs after injection.  Swollen hard area remains to 10/31/07.
then took the test on 07APR, and the result came out on 09APR which is positive.; exposed to someone who is COVID-19 positive on 28MAR, started to have symptoms on; This is a spontaneous report received from a Pfizer Sponsored Program received from contactable consumer (patient) reporting for himself. A male patient of an unspecified age received the bnt162b2 (PFIZER COVID-19 VACCINE, Lot number and expiry date for both doses were not reported), first dose on 09Jan2021 and second dose on 01Feb2021; both via an unspecified route of administration as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported.  The patient had his 1st shot on 09Jan2021 and 2nd shot on 01Feb2021. He was exposed to someone who is COVID-19 positive on 28Mar2021 started to have symptoms on 01Apr2021, then took the test on 07Apr2021, and the result came out on 09Apr2021, which was positive. He called to report his case since he was positive with the COVID-19. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
62-year-old male with PMH of COPD, chronic hypoxic respiratory failure on home O2 at 3 L,  atrial fibrillation, insulin-dependent diabetes, carotid artery disease, HTN, OSA, HLD and morbid obesity presented to the hospital today after having increased work of breathing, hypoxia with minimal exertion, right-sided chest pain and palpitations.  Patient has been suffering with positive at home coronavirus testing since August 7th.  Patient has been managing at home with oxygen and oral steroid treatment per his primary care doctor.  Over the last 3-4 days his work of breathing has increased.  Patient states that his oxygen saturation is as low as 84% when ambulating short distance.   Tested positive on 9/8/2021 62-year-old male with PMH of COPD, chronic hypoxic respiratory failure on home O2 at 3 L,  atrial fibrillation, insulin-dependent diabetes, carotid artery disease, HTN, OSA, HLD and morbid obesity presented to the hospital today after having increased work of breathing, hypoxia with minimal exertion, right-sided chest pain and palpitations.  Patient has been suffering with positive at home coronavirus testing since August 7th.  Patient has been managing at home with oxygen and oral steroid treatment per his primary care doctor.  Over the last 3-4 days his work of breathing has increased.  Patient states that his oxygen saturation is as low as 84% when ambulating short distance.  He usually does not have to wear his oxygen all the time, only at night but over the last month he has required 3 L continuously.  He has required 4 L over the last 4 days to maintain O2 sat greater than 90.  Patient has had a few episodes of nausea vomiting several days ago, denies diarrhea.  Laboratory evaluation is significant for lactic acidosis, hyperglycemia, hypo magnesemia.  COVID swab is positive.  Chest CT was obtained which revealed multifocal pneumonia, No evidence of central pulmonary emboli.  Sepsis is present on admission, weight based IV fluid resuscitation and antibiotics were initiated.            Otherwise, patient denies any recent fevers/chills/sweats/nausea/vomiting/productive cough/chest pain/chest pressure/palpitations/abdominal pain/diarrhea/constipation/frequency/urgency/dysuria/hematuria/hematemesis/melena.
This spontaneous report as received from a certified medical assistant refers to a patient of unknown age. On 16-OCT-2012, the patient was vaccinated with the first dose of VAQTA (route and lot # not reported) and on 12-DEC-2012, the patient received the second dose of VAQTA (route and lot # not reported). No adverse symptoms were reported. Additional information has been requested.
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and gender. The concurrent conditions, drug reactions/allergies and medical history of the patients were not reported. On unknown dates,  the patients were vaccinated with an improperly stored dose of VARIVAX with lot number M005973 and expiration date of 02-FEB-2018 (strength, dose, route of administration and anatomical location were unknown) for prophylaxis, which was stored at more than -15 Celsius degrees (°C) but less than -10 °C (more than 5 Fahrenheit degrees (°F) but less than 14°F) for 69 minutes. There was a previous temperature excursion of more than -10°C but less than 8°C (more than 14°F but less than 46°F) for 185 minutes. The temperature excursions were detected by a data logger. No concomitant therapies nor adverse effects were reported. This is one of two cases from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1702USA012187:
My wife just had the third booster shot; My wife just had the third booster shot; She has temperature of 103 may be a temperature of 105 under her armpit; Chills; Nausea; her growing hurt back pain; Leg pain; Injection site where they injected her it feels hot, she said the fire; This is a spontaneous report from a contactable consumer (patients husband). A 53-year-old female patient received third dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: ER8731) via an unspecified route of administration on 30Sep2021 11:00 (at the age of 53years) as dose 3 (BOOSTER), single for COVID-19 immunization. Medical history included Diabetes, High Blood pressure, she has high blood pressure and Diabetic and Cholesterol. Concomitant medications included Lisinopril taken for Blood pressure, Metformin taken for Diabetes, Atorvastatin taken for blood cholesterol. Previously patient received first dose and second dose bnt162b2 (PFIZER-BIONTECH COVID-19, Solution for injection,), dose 1, dose 2 unspecified route of administration on unspecified date as single dose for COVID-19 immunization. On unspecified date 2021 the patient experienced she has temperature of 103 may be a temperature of 105 under her armpit, chills, nausea, her growing hurt back pain, leg pain, injection site where they injected her it feels hot, she said the fire. On 30Sep2021 my wife just had the third booster shot. Reporter stated, my wife just had the third booster shot and she is experiencing chills, nausea, she has temperature of 103 may be a temperature of 105 under her armpit, her growing hurt back pain, leg pain injection site where they injected her it feels hot, she said the fire. Patient received treatment of Tylenol Dosage: 6 tablet 500 mg once a day. The patient underwent lab tests and procedures which included body temperature: 103 body temperature: 105 in 2021. The outcome of the events was unknown.
This case was reported by a physician via call center representative and described the occurrence of injection site pain in a 61-year-old female patient who received SHINGRIX (batch number N77EY ?, expiry date 8th February 2021) for prophylaxis. On 2nd August 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On 2nd August 2018, several hours after receiving SHINGRIX, the patient experienced injection site pain and headache. In August 2018, the outcome of the injection site pain and headache were recovered/resolved. It was unknown if the reporter considered the injection site pain and headache to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX around noon and she experienced serious pain at the injection site and headache which started at night on the day of her vaccination. The symptoms remained for 4 to 5 days and then resolved. The clarification was raised for the correct batch number, however the reply was not received.
This case was reported by a consumer via call center representative and described the occurrence of headache in a 60-year-old female patient who received SHINGRIX for prophylaxis. Co-suspect products included Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent 2018-2019 season) for prophylaxis. The patient's past medical history included chickenpox (as a child, severe case). Previously administered products included Flu vaccine with an associated reaction of influenza (also experienced low grade fever, refer case US2018GSK212776). On 1st August 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. In September 2018, the patient received Influenza vaccine Quadrivalent 2018-2019 season. On 1st August 2018, less than a day after receiving SHINGRIX and not applicable after receiving Influenza vaccine Quadrivalent 2018-2019 season, the patient experienced headache, shivering, pain in arm, erythema of extremities and stomach pain. On 2nd August 2018, the patient experienced fever, nausea and tiredness. In October 2018, the patient experienced cold. On an unknown date, the outcome of the headache, shivering, fever, pain in arm, erythema of extremities, nausea, cold, stomach pain and tiredness were recovered/resolved. It was unknown if the reporter considered the headache, shivering, fever, pain in arm, erythema of extremities, nausea, stomach pain and tiredness to be related to SHINGRIX. It was unknown if the reporter considered the cold to be related to Influenza vaccine Quadrivalent 2018-2019 season. Additional details were provided as follows: The age at vaccination was not reported. The patient received a dose of SHINGRIX at 12:30, later that day the patient had a headache and stomachache. She took her temperature and it was 97 degree F. Later that evening the patient started shivering so much that she could not sleep. The next day the patient had a bad headache, felt tired and nauseous. She had a temperature of 101.1 degree F. The patient's arm was sore and red for a day and a half.  At the beginning of October 2018 after receiving flu vaccine, the patient experienced cold. The patient had denied permission to contact their physician.
Fever, Chills, Headache, arm soreness all on the night of vaccination, all lasting for about a day except the fever. The fever stayed over 100F and lasted until May 4th,  7 days after I received the vaccine. I would take acetaminophen , which helped for only a few hours at a time, but the fever never subsided until the following week.
Started getting sick around Thanksgiving my feet started getting numb and I started to fall (at least 3 times) My legs wouldn't work. My son had to carry me so I could get around. I got a wheelchair in order to get to the Doctor's office. Dr. did tests and I was hospitalized. My Left big toe went black. I need rehab and I can't be left alone. My arms are heavy and they don't always work either. My fingers get numb alot. My doctor told me I had Guillian-Barre Syndrome. I had no idea what that was.
This case was reported by a consumer and described the occurrence of a rash in a 10 yr old male subject who was vaccinated with hep A vaccine (Havrix) for prophylaxis. The reporter is the subject's mother. A physician or other healthcare professional has not verified this report. There were no concurrent medications. On 14Dec05 the subject received 2nd dose of Havrix (lot number not specified). On 16Dec05, two days after vaccination with Havrix, the subject experienced rash and urticaria. The subject was treated with diphenhydramine hydrochloride (Benadryl) and the evens resolved. The mother stated the rash and urticaria occurred again on 23Dec05, 24Dec05, and 25Dec05 and resolved each day after treatment with diphenhydramine hydrochloride (Benadryl).
Achy (sore) arm at the injection site; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 58-year-old male patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season. On an unknown date, less than a year after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was recovered/resolved.   The reporter considered the injection site pain to be related to Influenza vaccine Quadrivalent unspecified season.  Additional details were provided as follows: The patient had reported the case for himself. The age at vaccination was not reported. The patient received the flu shot every year and experienced an achy (sore) arm at the injection site. The reporter consented to follow-up. This was 1 of the 3 cases reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021012496:Same reporter. US-GLAXOSMITHKLINE-US2021AMR013283:Same reporter. US-GLAXOSMITHKLINE-US2021AMR013283:Same reporter
Moderna COVID-19 vaccine EUA 4-5 hours after vaccination, I started feeling sick: body aches, after that, during the night in addition to that I had a head ache. After that, i started feeling better. About 24 hours after the vaccination I started feeling worse again with body aches and headache. All my body was sick. During the night I had chills and a fever of 99.7. I felt sick and very tired all next day. More head ache and body aches. Was taking Tylenol every 5-6 hours, including the morning of day 5.
Today 5/10/12 Pt. returned to clinic for ppd test check/result. Mentioned that yesterday on 5/9/12 she felt very sick and gasping for breath, nauseated and headache from 5 am until about 8 am, but she did attend classes all day. Says the injection site was and is not red and hot, with swelling. Says that today her stomach is sore from having hard time to breathe, and now is okay, just feels tired. Had no complaints on 5/8/12 day of shot and no breathing problems. Received varicella dose and ppd test at same time on 5/8/12. I note the site to be red, hot, and swollen. Patient did not see medical treatment and will go if feeling bad again.
pt recvd vax & several hrs post vax exp abd cramps,flu-like syndrome & swollen lymph nodes;sx resolved w/in 7 days;no further problems reported;
Pain 1 hr after injections on left side L-arm swelling that night severe pain swelling in armpit and radiating to breast. Some fatigue and nausea, rash on left delt. Pt is scheduled to follow up w/provider tomorrow 12/14/18 to see how she is doing.
nodule on her left deltoid after receiving the second dose of GARDASIL 9; This spontaneous report has been received from a medical assistant, regarding an 18-years-old female patient. The patient's pertinent medical history included allergy to amoxicillin trihydrate (+) clavulanate potassium (AUGMENTIN), concomitant medications included salbutamol (ALBUTEROL).  On 05-NOV-2022 and 06-JAN-2023, the patient was vaccinated with the first and second dose respectively of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) injection, as prophylaxis (lot number: W001498, which was determined to be valid, with an expiration date on 15-SEP-2024, for first dose it was also reported as W0011498, conflicting information and confirmed as non-valid by the validation lot team) (strengths, doses, routes and anatomical locations of administration were not reported).  On 07-JAN-2023, after receiving the second dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9), the patient developed a nodule on her left deltoid (vaccination site nodule). By the time of the report, the patient has not gotten the third dose yet, and the nodule got smaller but it's still on her arm (recovering).  No further information provided.  The causal relationship between vaccination site nodule and HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) was not provided.
High fever 103.5 for 2 days now, bad swollen left arm and big lump in my armpit that is painfull
Red, itchy rash at injection site was first noticed 5 days after injection. Itching successfully treated with hydrocortisone ointment, and stopped itching completely  after about 4 days. Redness remained for another 2 weeks.